SEC Form D filing
Gaius Therapeutics, Inc,
Biotech · Seed · Regulation D 506(b) · CA · Filed May 14, 2026
- Offering amount
- $250.0K
- Exemption
- Reg D 506(b)
- Issuer state
- CA
- Filing date
- May 14, 2026
- Signature date
- May 14, 2026
- CIK
- 0002132841
Public filing directories
Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Summary
Auto-generated$250k Gaius Therapeutics early-stage biotech in seed range.
Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.